We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+13.49%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.34B
AUM Growth
-$346M
Cap. Flow
-$728M
Cap. Flow %
-21.78%
Top 10 Hldgs %
68.3%
Holding
475
New
106
Increased
41
Reduced
44
Closed
201

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Industrials 16.01%
3 Healthcare 15.52%
4 Communication Services 12.09%
5 Financials 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYF
451
X Financial
XYF
$204M
-205,614
Closed -$3.59M
YMM icon
452
Full Truck Alliance
YMM
$8.97B
-186,090
Closed -$2.2M
GEV icon
453
GE Vernova
GEV
$251B
-1,680
Closed -$889K
FAASW
454
DELISTED
DigiAsia Corp Warrant
FAASW
-135,667
Closed -$5.72K
BACQR
455
DELISTED
Inflection Point Acquisition Corp IV Right
BACQR
-250,000
Closed -$81K
TTAN
456
ServiceTitan Inc
TTAN
$8.39B
-50,000
Closed -$5.36M
PVLA
457
Palvella Therapeutics
PVLA
$2.27B
-43,994
Closed -$992K
ONC
458
BeOne Medicines Ltd
ONC
$40.5B
-9,377
Closed -$2.27M
XAGEW
459
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
-371,250
Closed -$11.3K
CRWV
460
PUT
CoreWeave
CRWV
$49.3B
-100,000
Closed -$10.3K
FLYY
461
DELISTED
Spirit Aviation Holdings, Inc.
FLYY
-1,156,492
Closed -$5.77M
OYSEU
462
Oyster Enterprises II Acquisition Corp Units
OYSEU
-100,000
Closed -$1.01M
BRR
463
ProCap Financial Inc
BRR
$235M
-200,000
Closed -$2.12M

Similar funds

UBS O'Connor's Q3 2025 Portfolio in Review

As of Q3 2025, UBS O'Connor held 475 positions worth $3.34B, down 9.4% from $3.69B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

UBS O'Connor withdrew a net $728M in Q3 2025, closing 201 positions and reducing 44 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $288M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Verona Pharma worth $457M.

  • UBS O'Connor's largest Q3 2025 buy was Verona Pharma: 4,283,462 shares worth $457M.
  • UBS O'Connor added most to Interpublic Group of Companies in Q3 2025, an estimated $96.3M increase.
  • UBS O'Connor's biggest Q3 2025 reduction was Kellanova, cutting an estimated $110M.
  • UBS O'Connor fully exited Walgreens Boots Alliance in Q3 2025, selling an estimated $288M.
  • UBS O'Connor's ten largest holdings make up 68% of its $3.34B portfolio in Q3 2025.
  • UBS O'Connor opened 106 new positions and closed 201 in Q3 2025.
  • UBS O'Connor's portfolio value fell 9.4% quarter-over-quarter to $3.34B.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.